A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder
- 285 Downloads
The study purpose was to compare the quantitative results from tests for urinary porphyrins, where some of these porphyrins are known biomarkers of heavy metal toxicity, to the independent assessments from a recognized quantitative measurement, the Autism Treatment Evaluation Checklist (ATEC), of specific domains of autistic disorders symptoms (Speech/Language, Sociability, Sensory/Cognitive Awareness, and Health/Physical/Behavior) in a group of children having a clinical diagnosis of autism spectrum disorder (ASD). After a Childhood Autism Rating Scale (CARS) evaluation to assess the development of each child in this study and aid in confirming their classification, and an ATEC was completed by a parent, a urinary porphyrin profile sample was collected and sent out for blinded analysis. Urinary porphyrins from twenty-four children, 2–13 years of age, diagnosed with autism or PDD-NOS were compared to their ATEC scores as well as their scores in the specific domains (Speech/Language, Sociability, Sensory/Cognitive Awareness, and Health/Physical/Behavior) assessed by ATEC. Their urinary porphyrin samples were evaluated at Laboratoire Philippe Auguste (which is an ISO-approved clinical laboratory). The results of the study indicated that the participants’ overall ATEC scores and their scores on each of the ATEC subscales (Speech/Language, Sociability, Sensory/Cognitive Awareness, and Health/Physical/Behavior) were linearly related to urinary porphyrins associated with mercury toxicity. The results show an association between the apparent level of mercury toxicity as measured by recognized urinary porphyrin biomarkers of mercury toxicity and the magnitude of the specific hallmark features of autism as assessed by ATEC.
KeywordsToxicity Mercury CARS ATEC ASDs Asperger’s Autism PDD-NOS Porphyrins Biomarkers Susceptibility
This research was funded by a grant from the Autism Research Institute, non-profit CoMeD, Inc., and by the non-profit Institute of Chronic Illnesses, Inc. through a grant from the Brenen Hornstein Autism Research & Education (BHARE) Foundation. The authors wish to acknowledge the help of the parents and children who participated in the study; without their participation this type of investigation would not be possible.
Conflict of interest statement
David Geier, Janet Kern, and Mark Geier have been involved in vaccine/biologic litigation.
- Adams JB, Baral M, Geis E, Mitchel JL, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin R.A, Mitchell K, Bradstreet J, El-Dahr JJM (2009) The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J Toxicol. doi: 10.1155/2009/532640
- American Psychiatric Association (2000) Diagnostic criteria for autistic disorder. In Diagnostic and statistical manual of mental disorders (Fourth edition—text revision (DSM-IV-TR). American Psychiatric Association, Washington, DC, p 75Google Scholar
- Blaylock RL (2008) A possible central mechanism in autism spectrum disorders, part 1. Altern Ther in Health Med 14(6):46–53Google Scholar
- Bradstreet J, Geier DA, Kartzinel JJ, Adams JB, Geier MR (2003) A case-control study of mercury burden in children with autistic spectrum disorders. J Am Phys Surg 8(3):76–79Google Scholar
- Schopler E, Reichler RJ, Renner BR (1994) The Childhood Autism Rating Scale. Western Psychological Services, 12031 Wilshire Boulevard, Los Angeles, California, 90025-91251Google Scholar
- Stringari J, Nunes AK, Franco JL, Bohrer D, Garcia SC, Dafre AL, Milatovic D, Souza DO, Rocha JB, Aschner M, Farina M (2008) Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol 227(1):147–154CrossRefPubMedGoogle Scholar
- Waly M, Olteanu H, Banjeree R, Choi SW, Manson JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Charnitsky VA, Deth RC (2004) Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry 9:358–370CrossRefPubMedGoogle Scholar
- Woods JS, Martin MD, Leroux BG, DeRouen TA, Bernardo MF, Luis HS, Leitao JG, Simmonds PL, Echeverria D, Rue TC (2009) Urinary porphyrins excretion in children with mercury amalgam treatment: findings from the Casa Pia Children’s Dental Amalgam Trial. J Toxicol Environ Health A 72(14):891–896CrossRefPubMedGoogle Scholar